Mitoxantrone and white blood cell count decreased Patient Reports February 12, 2012

Mitoxantrone Side Effects Report #5524987-9
Mitoxantrone side effect was reported by a Consumer or non-health professional from CHINA on Nov 01, 2007. Male patient, 71 years of age, weighting 121.3 lb, was diagnosed with prostate cancer  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: discomfort, neutropenic infection, pulmonary fibrosis , respiratory failure, white blood cell count decreased. Mitoxantrone dosage: 20 MG Q3W IV. During the same period patient was treated with PREDNISONE. Patient died on 10/28/2007.

Mitoxantrone Side Effects Report #5376676-1
Mitoxantrone side effect was reported by a Consumer or non-health professional from CHINA on June 21, 2007. Male patient, 62 years of age, weighting 154.3 lb, was diagnosed with prostate cancer  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: calculus bladder, urinary tract infection , white blood cell count decreased. Mitoxantrone dosage: 20 MG CYC IV. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #4649202-X
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Apr 13, 2005. Female patient, 35 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, white blood cell count decreased. Mitoxantrone dosage: 20 MG, 1 IN 1 CYCLE, INTRAVENOUS. During the same period patient was treated with VENLAFAXINE, CLONAZEPAM, FOLIC ACID, DIHYDROERGOTAMINE MESYLATE, TROPSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #4692429-1
Mitoxantrone side effect was reported by a Consumer or non-health professional from on June 01, 2005. Female patient, 35 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, white blood cell count decreased. Mitoxantrone dosage: 20 MG, 1 IN 1 CYCLE, INTRAVENOUS. During the same period patient was treated with VENLAFAXINE, CLONAZEPAM, FOLIC ACID, DIHYDROERGOTAMINE MESYLATE, TROSPIUM CHLORIDE. Patient was hospitalized. Patient recovered.


Mitoxantrone Side Effects Report #4805103-5
Mitoxantrone side effect was reported by a Physician from GERMANY on Sept 29, 2005. Male patient, 24 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: cardiomyopathy , ejection fraction decreased, white blood cell count decreased. Mitoxantrone dosage: 12 MG/M2. Patient recovered.

Mitoxantrone Side Effects Report #5883949-2
Mitoxantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 12, 2008. Male patient, weighting 248.5 lb, was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, limb injury, oedema peripheral, white blood cell count decreased. Mitoxantrone dosage: 72 MG. Patient recovered.